• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心肌病患者接受外科治疗后左心室功能恢复的发生率、决定因素和临床影响。

Incidence, determinants and clinical impact of left ventricular function recovery after surgical treatments for ischaemic cardiomyopathy.

机构信息

Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Division of Biomedical Statistics, Department of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita, Japan.

出版信息

Eur J Cardiothorac Surg. 2021 Sep 11;60(3):689-696. doi: 10.1093/ejcts/ezab122.

DOI:10.1093/ejcts/ezab122
PMID:33779701
Abstract

OBJECTIVES

This retrospective study aimed to clarify the incidence, determinants and clinical impact of left ventricular (LV) function non-recovery after coronary artery bypass grafting (CABG) in patients with ischaemic cardiomyopathy.

METHODS

A total of 490 patients with ischaemic cardiomyopathy (LV ejection fraction ≤ 40%) undergoing CABG were analysed. Follow-up echocardiography was performed at 1 month, 1 year, and annually thereafter. LV function recovery was defined as ejection fraction (EF) ≥40% at least once during follow-up. LV function non-recovery was defined as EF <40% at any follow-up. The primary and secondary end points were changes in LV function and all-cause mortality, respectively. Clinical follow-up was completed in 461 patients (94.1%; mean follow-up: 64.5 ± 45.5 months).

RESULTS

During follow-up, echocardiographic assessments were performed 1863 times (mean, 3.8 ± 2.4), and 193 patients (39.4%) exhibiting LV function non-recovery were identified. Overall survival was significantly higher in the recovery group (53.9%) than in the non-recovery group (31.4%) at 10 years (P < 0.001). Independent predictors of LV function non-recovery were preoperative LV end-systolic diameter [odds ratio (OR) 1.07, 95% confidence interval (CI) 1.04-1.10; P < 0.001] and bilateral internal thoracic artery grafting (OR 0.61, 95% CI 0.39-0.95; P = 0.028). In a multivariable Cox proportional hazards model, LV function non-recovery was significantly associated with all-cause mortality (hazard ratio 2.14, 95% CI 1.60-2.86; P < 0.001).

CONCLUSIONS

Almost 40% of patients with ischaemic cardiomyopathy undergoing CABG did not achieve LV function recovery and were associated with poor prognosis. To achieve LV function recovery, CABG with bilateral internal thoracic artery may be recommended before excessive LV remodelling occurs.

CLINICAL TRIAL REGISTRATION NUMBER

Institutional review board of Osaka University Hospital, number 16105.

摘要

目的

本回顾性研究旨在阐明缺血性心肌病患者冠状动脉旁路移植术后(CABG)左心室(LV)功能无法恢复的发生率、决定因素和临床影响。

方法

分析了 490 例缺血性心肌病(LV 射血分数≤40%)患者的资料,所有患者均接受了 CABG 治疗。术后 1 个月、1 年以及此后每年进行随访超声心动图检查。LV 功能恢复定义为至少一次随访时射血分数(EF)≥40%。LV 功能未恢复定义为任何随访时 EF<40%。主要终点和次要终点分别为 LV 功能变化和全因死亡率。461 例患者(94.1%;平均随访:64.5±45.5 个月)完成了临床随访。

结果

随访期间共进行了 1863 次超声心动图评估(平均 3.8±2.4 次),193 例(39.4%)患者出现 LV 功能未恢复。10 年时,恢复组(53.9%)的总体生存率明显高于未恢复组(31.4%)(P<0.001)。LV 功能未恢复的独立预测因素为术前 LV 收缩末期直径[比值比(OR)1.07,95%置信区间(CI)1.04-1.10;P<0.001]和双侧胸廓内动脉旁路移植(OR 0.61,95%CI 0.39-0.95;P=0.028)。多变量 Cox 比例风险模型显示,LV 功能未恢复与全因死亡率显著相关(风险比 2.14,95%CI 1.60-2.86;P<0.001)。

结论

近 40%接受 CABG 的缺血性心肌病患者未实现 LV 功能恢复,且预后不良。为了实现 LV 功能恢复,在 LV 重构过度发生之前,可能建议使用双侧胸廓内动脉进行 CABG。

临床试验注册号

大阪大学医院机构审查委员会,编号 16105。

相似文献

1
Incidence, determinants and clinical impact of left ventricular function recovery after surgical treatments for ischaemic cardiomyopathy.缺血性心肌病患者接受外科治疗后左心室功能恢复的发生率、决定因素和临床影响。
Eur J Cardiothorac Surg. 2021 Sep 11;60(3):689-696. doi: 10.1093/ejcts/ezab122.
2
Impact of left ventricular remodelling on outcomes after left ventriculoplasty for ischaemic cardiomyopathy: Japanese surgical ventricular reconstruction group experience.左心室重塑对缺血性心肌病左心室成形术后结局的影响:日本外科心室重建组的经验
Interact Cardiovasc Thorac Surg. 2013 Jun;16(6):785-91. doi: 10.1093/icvts/ivt096. Epub 2013 Mar 8.
3
Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).比较左心室射血分数≤50%与>50%的患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗的 5 年预后(来自 CREDO-Kyoto PCI/CABG 注册研究队列-2)。
Am J Cardiol. 2014 Oct 1;114(7):988-96. doi: 10.1016/j.amjcard.2014.07.007. Epub 2014 Jul 16.
4
Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery.局部左心室功能无法预测心脏手术后缺血性心肌病患者的生存率。
Heart. 2017 Sep;103(17):1359-1367. doi: 10.1136/heartjnl-2016-310693. Epub 2017 Apr 26.
5
A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio.一种新的标记物可用于预测围生期心肌病患者持续性左心室收缩功能障碍:单核细胞计数/高密度脂蛋白胆固醇比值。
BMC Cardiovasc Disord. 2019 May 15;19(1):114. doi: 10.1186/s12872-019-1100-9.
6
Restrictive mitral annuloplasty with or without coronary artery bypass grafting in ischemic mitral regurgitation.缺血性二尖瓣反流伴或不伴冠状动脉旁路移植术的限制性二尖瓣环成形术。
ESC Heart Fail. 2020 Aug;7(4):1560-1570. doi: 10.1002/ehf2.12705. Epub 2020 May 13.
7
Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy.非缺血性扩张型心肌病患者预防性植入式心脏转复除颤器植入后的左心室功能改善。
Europace. 2013 Nov;15(11):1594-600. doi: 10.1093/europace/eut097. Epub 2013 May 2.
8
Does the extended use of arterial grafts compromise the myocardial recovery after coronary artery bypass grafting in left ventricular dysfunction?在左心室功能不全的患者中,冠状动脉旁路移植术中延长动脉移植物的使用是否会影响心肌恢复?
Eur J Cardiothorac Surg. 1998 Oct;14(4):353-9. doi: 10.1016/s1010-7940(98)00219-x.
9
Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction.左心室功能不全患者冠状动脉搭桥手术近期和远期预后的预测因素
Heart Vessels. 2016 Jul;31(7):1045-55. doi: 10.1007/s00380-015-0714-9. Epub 2015 Jul 15.
10
Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.多支冠状动脉疾病合并左心室功能障碍患者经皮冠状动脉介入治疗与冠状动脉旁路移植术后左心室功能的恢复情况比较
Hawaii J Med Public Health. 2016 Sep;75(9):273-7.

引用本文的文献

1
Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial.异体脂肪源性干细胞喷雾移植治疗缺血性心肌病的安全性和治疗潜力:一项I期临床试验
J Transl Med. 2024 Dec 2;22(1):1091. doi: 10.1186/s12967-024-05816-1.
2
TIMP-1 in the prognosis of patients who underwent coronary artery bypass surgery: a 12-year follow-up study.基质金属蛋白酶组织抑制因子-1在冠状动脉搭桥手术患者预后中的作用:一项12年的随访研究。
Front Cardiovasc Med. 2023 Dec 14;10:1226449. doi: 10.3389/fcvm.2023.1226449. eCollection 2023.
3
Prediction of left ventricular ejection fraction improvement in patients with ischemic cardiomyopathy after coronary artery bypass grafting based on cardiac magnetic resonance.
基于心脏磁共振成像预测缺血性心肌病患者冠状动脉搭桥术后左心室射血分数的改善情况。
Cardiovasc Diagn Ther. 2023 Dec 15;13(6):1003-1018. doi: 10.21037/cdt-23-220. Epub 2023 Dec 6.
4
Myocardial infarct size for predicting improvements in cardiac function in patients with ischemic cardiomyopathy following coronary artery bypass grafting.预测冠状动脉搭桥术后缺血性心肌病患者心功能改善情况的心肌梗死面积
Quant Imaging Med Surg. 2023 Dec 1;13(12):7814-7827. doi: 10.21037/qims-23-159. Epub 2023 Oct 9.
5
Clinical Outcomes by Consolidation of Bone Marrow Stem Cell Therapy and Coronary Artery Bypass Graft in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-analysis.骨髓干细胞治疗联合冠状动脉旁路移植术治疗射血分数降低的心力衰竭患者的临床结局:一项荟萃分析。
Cell Transplant. 2023 Jan-Dec;32:9636897231152381. doi: 10.1177/09636897231152381.
6
Enhanced myocardial blood flow in ischemic cardiomyopathy by a slow-release synthetic prostacyclin agonist combined with coronary artery bypass grafting: The first human study in a Phase I/IIa clinical trial.缓释合成前列环素激动剂联合冠状动脉搭桥术改善缺血性心肌病患者的心肌血流:一项I/IIa期临床试验的首例人体研究。
Front Cardiovasc Med. 2023 Jan 25;10:1047666. doi: 10.3389/fcvm.2023.1047666. eCollection 2023.
7
Retrospective, observational analysis of cardiac function associated with global preoperative myocardial scar in patients with ischemic cardiomyopathy after coronary artery bypass grafting.对冠状动脉旁路移植术后缺血性心肌病患者术前整体心肌瘢痕相关心功能的回顾性观察分析。
J Thorac Dis. 2022 Nov;14(11):4319-4328. doi: 10.21037/jtd-22-846.